Trial intelligence / Profile preview

Mirtazapine versus placebo in functional dyspepsia

2006-003194-27Phase 4Completed

Sponsor
UZ Leuven
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in functional dyspepsia (FD) comparing Mirtazapine with Placebo (2 arms). Primary endpoint: Global dyspepsia symptom score improvement at 8 weeks. Started Aug 2006; status: completed.

02

Drugs

mirtazapine
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on 2006-003194-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003194-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call